Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation

Journal of Cellular Biochemistry

Volumn 107, Issue 2, 2009, Pages 303-315

  Wong, Vincent Kam Wai ^a   Zhou, Hua ^a   Cheung, Simon Shiu Fai ^a   Li, Ting ^a   Liu, Liang ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

AP 1; NF B; NF AT; Saikosaponin D; T lymphocyte activation

Indexed keywords

CD28 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; I KAPPA B ALPHA; I KAPPA B BETA; I KAPPA B KINASE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; IONOMYCIN; OKT 3; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE B; SAIKOSAPONIN D; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; OLEANOLIC ACID; SAPONINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTOR AP-1;

APIACEAE; BACTERIA (MICROORGANISMS); BUPLEURUM FALCATUM; MURINAE;

EID: 66149145372     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22126     Document Type: Article

References (50)

1. Aggarwal BB. 2004. Nuclear factor-kappaB: The enemy within. Cancer Cell 6:203-208.
2. Bauer B, Krumbock N, Fresser F, Hochholdinger F, Spitaler M, Simm A, Uberall F, Schraven B, Baier G. 2001. Complex formation and cooperation of protein kinase C theta and Akt1/protein kinase B alpha in the NF-kappa B transactivation cascade in Jurkat T cells. J Biol Chem 276:31627-31634.
3. Belardelli F. 1995. Role of interferons and other cytokines in the regulation of the immune response. APMIS 103:161-179.
4. Bermejo Benito P, Abad Martinez MJ, Silvan Sen AM, Sanz Gomez A, Fernandez Matellano L, Sanchez Contreras S, Diaz Lanza AM. 1998. In vivo and in vitro antiinflammatory activity of saikosaponins. Life Sci 63:1147-1156.
5. Chiariello M, Marinissen MJ, Gutkind JS. 2000. Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation. Mol Cell Biol 20:1747-1758.
6. Coudronniere N, Villalba M, Englund N, Altman A. 2000. NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta. Proc Natl Acad Sci USA 97:3394-3399.
7. Crabtree GR, Clipstone NA. 1994. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu Rev Biochem 63:1045-1083.
8. de Gregorio R, Iniguez MA, Fresno M, Alemany S. 2001. Cot kinase induces cyclooxygenase-2 expression in T cells through activation of the nuclear factor of activated T cells. J Biol Chem 276:27003-27009.
9. Gao X, Kuo J, Jiang H, Deeb D, Liu Y, Divine G, Chapman RA, Dulchavsky SA, Gautam SC. 2004. Immunomodulatory activity of curcumin: Suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol 68:51-61.
10. Gately MK, Desai BB, Wolitzky AG, Quinn PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizonnite R, Gubler U. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 147:874-882.
11. Ghosh S, Karin M. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl):S81-S96.
12. Hacker H, Karin M. 2006. Regulation and function of IKK and IKK-related kinases. Sci STKE 357:re13.
13. Iniguez MA, Martinez-Martinez S, Punzon C, Redondo JM, Fresno M. 2000. An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J Biol Chem 275:23627-23635.
14. Jhun BS, Lee JY, Oh YT, Lee JH, Choe W, Baik HH, Kim SS, Yoon KS, Ha J, Kang I. 2006. Inhibition of AMP-activated protein kinase suppresses IL-2 expression through down-regulation of NF-AT and AP-1 activation in Jurkat T cells. Biochem Biophys Res Commun 351:986-992.
15. Karin M, Greten FR. 2005. NF-kappaB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749-759.
16. Kato M, Pu MY, Isobe K, Iwamoto T, Nagase F, Lwin T, Zhang YH, Hattori T, Yanagita N, Nakashima I. 1994. Characterization of the immunoregulatory action of saikosaponin-d. Cell Immunol 159:15-25.
17. Kato M, Pu MY, Isobe K, Hattori T, Yanagita N, Nakashima I. 1995. Cell type-oriented differential modulatory actions of saikosaponin-d on growth responses and DNA fragmentation of lymphocytes triggered by receptor-mediated and receptor-bypassed pathways. Immunopharmacology 29:207-213.
18. Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S, Benkirane M. 2003. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem 278:2758-2766.
19. Kunsch C, Lang RK, Rosen CA, Shannon MF. 1994. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. J Immunol 153:153-164.
20. Leung CY, Liu L, Wong RN, Zeng YY, Li M, Zhou H. 2005. Saikosaponin-d inhibits T cell activation through the modulation of PKCtheta, JNK, and NF-kappaB transcription factor. Biochem Biophys Res Commun 338:1920-1927.
21. Lin X, Cunningham ET, Jr., Mu Y, Geleziunas R, Greene WC. 1999. The protooncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases. Immunity 10:271-280.
22. Lin X, O'Mahony A, Mu Y, Geleziunas R, Greene WC. 2000. Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta. Mol Cell Biol 20:2933-2940.
23. Macian F, Lopez-Rodriguez C, Rao A. 2001. Partners in transcription: NFAT and AP-1. Oncogene 20:2476-2489.
24. Maggirwar SB, Harhaj EW, Sun SC. 1997. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors. Mol Cell Biol 17:2605-2614.
25. Malnou CE, Salem T, Brockly F, Wodrich H, Piechaczyk M, Jariel-Encontre I. 2007. Heterodimerization with Jun family members regulates c-Fos nucleocytoplasmic traffic. J Biol Chem 282:31046-31059.
26. Marquez N, Sancho R, Macho A, Calzado MA, Fiebich BL, Munoz E. 2004. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors. J Pharmacol Exp Ther 308:993-1001.
27. Matsumoto R, Wang D, Blonska M, Li H, Kobayashi M, Pappu B, Chen Y, Lin X. 2005. Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation. Immunity 23:575-585.
28. Nguyen T, Wang R, Russell JH. 2000. IL-12 enhances IL-2 function by inducing CD25 expression through a p38 mitogen-activated protein kinase pathway. Eur J Immunol 30:1445-1452.
29. Oum JH, Han J, Myung H, Hleb M, Sharma S, Park J. 2002. Molecular mechanism of NFAT family proteins for differential regulation of the IL-2 and TNF-alpha promoters. Mol Cells 13:77-84.
30. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. 1999. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85.
31. Park KR, Lee JH, Choi C, Liu KH, Seog DH, Kim YH, Kim DE, Yun CH, Yea SS. 2007. Suppression of interleukin-2 gene expression by isoeugenol is mediated through down-regulation of NF-AT and NF-kappaB. Int Immunopharmacol 7:1251-1258.
32. Recio MC, Just MJ, Giner RM, Manez S, Rios JL, Hostettmann K. 1995. Antiinflammatory activity of saikosaponins from Heteromorpha trifoliata. J Nat Prod 58:140-144.
33. Sancho R, Macho A, de La Vega L, Calzado MA, Fiebich BL, Appendino G, Munoz E. 2004. Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways. J Immunol 172:2341-2351.
34. Schulze-Koops H, Kalden JR. 2001. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract Res Clin Rheumatol 15:677-691.
35. Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA, Crabtree GR. 1988. Identification of a putative regulator of early T cell activation genes. Science 241:202-205.
36. Sizemore N, Leung S, Stark GR. 1999. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol 19:4798-4805.
37. Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR. 2002. Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. J Biol Chem 277:3863-3869.
38. Skurkovich B, Skurkovich S. 2003. Anti-interferon-gamma antibodies in the treatment of autoimmune diseases. Curr Opin Mol Ther 5:52-57.
39. Smith KA. 1988. Interleukin-2: Inception, impact, and implications. Science 240:1169-1176.
40. Su B, Karin M. 1996. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol 8:402-411.
41. Tanos T, Marinissen MJ, Leskow FC, Hochbaum D, Martinetto H, Gutkind JS, Coso OA. 2005. Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. J Biol Chem 280:18842-18852.
42. Ushio Y, Abe H. 1991. The effects of saikosaponin on macrophage functions and lymphocyte proliferation. Planta Med 57:511-514.
43. Ushio Y, Oda Y, Abe H. 1991. Effect of saikosaponin on the immune responses in mice. Int J Immunopharmacol 13:501-508.
44. Vockerodt M, Tesch H, Kube D. 2001. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway. Genes Immun 2:433-441.
45. Wang YL, He SX, Luo JY. 2006. [Progress in research on antitumor activity of saikosaponin and its mechanism]. Zhong Xi Yi Jie He Xue Bao 4:98-100.
46. Whitmarsh AJ, Davis RJ. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589-607.
47. Woods JM, Mogollon A, Amin MA, Martinez RJ, Koch AE. 2003. The role of COX-2 in angiogenesis and rheumatoid arthritis. Exp Mol Pathol 74:282-290.
48. Xiao BG, Link H. 1999. Antigen-specific T cells in autoimmune diseases with a focus on multiple sclerosis and experimental allergic encephalomyelitis. Cell Mol Life Sci 56:5-21.
49. Yea SS, Jeong HS, Choi CY, Park KR, Oh S, Shin JG, Yun CH. 2006. Inhibitory effect of anethole on T-lymphocyte proliferation and interleukin-2 production through down-regulation of the NF-AT and AP-1. Toxicol In Vitro 20:1098-1105.
50. Zhong H, Voll RE, Ghosh S. 1998. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1:661-671.